GoodRx (GDRX) Stock: $50 Target By RBC Capital

By Amit Chowdhry ● May 16, 2021
  • The shares of GoodRx Holdings Inc (NASDAQ: GDRX) have received a price target decrease from $56 to $50 by RBC Capital. These are the details. 

The shares of GoodRx Holdings Inc (NASDAQ: GDRX) have received a price target decrease from $56 to $50 by RBC Capital. And RBC Capital analyst Sean Dodge is maintaining an “Outperform” rating on the company shares.

Dodge said that the company’s first quarter monthly active consumers count of 5.7 million was considered disappointing, but that metric had improved considerably from the company’s March levels. And Dodge also noted that GoodRx is exiting the first quarter with a strong trajectory.

Plus Dodge pointed out that the improving “Other” revenue outlook and the lift from normalizing health care volumes is keeping the long-term growth story on track.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.